If geometric control, not retention, is the priority in viral vector separation, research group says high-resolution 3D-printing chromatography monoliths can be useful.
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Closing The CAR-T Access Gap With Hospital-Based Manufacturing
- How To Stand Up A Hospital-Based CAR-T Manufacturing Network
- September 2026 — CDMO Opportunities And Threats Report
- An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
- Is Your Supply Chain Ready For The End Of Class VI?
- Demonstrating Gene Therapy Potency: A Strategic Road Map
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Mid-Sized Pharma Optimizes Local Affiliate Safety Operations
Managing local affiliate PV strains any team. See how a mid-sized biopharma standardized ICSR processing across 94 countries, improved compliance tracking, and achieved centralized oversight.
-
What FDA CRLs Reveal About E&L
FDA feedback shows E&L gaps still delay approvals. This preview flags common issues — from unknown compounds to weak tox data — and offers ways to strengthen E&L approaches and cut regulatory risk.
-
Phase-Appropriate Approaches To Manufacturing And Testing
Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.
-
Expansion Of Human Bone Marrow-Derived MSCs
Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.
-
Evaluating Carryover When Using A TOC Analyzer
Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.
-
Ex-Vivo T Cell Depletion In Allogeneic HSCT
Explore a flexible cell depletion strategy that selectively removes targeted immune cell populations while preserving beneficial subsets, supporting tailored graft engineering approaches.
-
Direct Cell Lysis Enables Rapid And Robust Vector Copy Number (VCN) Quantification Using QIAcuity Digital PCR
Explore a faster approach to vector copy number measurement that replaces DNA extraction with direct cell lysis and digital PCR, delivering accurate, reproducible results across fresh and frozen samples.
-
Integrated Upstream And Downstream Strategies For Robust Manufacturing
Process robust mAb production requires understanding scale dependent cell environments, leveraging predictive models, and pursuing data driven control to minimize variability and optimize quality.
-
Pouching Solutions For Sterile And Moisture-Sensitive Devices
Aseptic pouching requires specialized mechanical segregation and sterile vacuum handling. Discover how targeted engineering maintains Grade A compliance.
-
Comparison Of Different Methods To Isolate HMW DNA From Bacteria
Different extraction methods produce dramatically different DNA sizes and qualities, directly affecting long‑read sequencing results. See how performing early QC can improve sequencing success.
NEWSLETTER ARCHIVE
- 11.03.26 -- Where Speed Is Lost: Fixing Handoffs In BioPharma Operations
- 11.03.26 -- How Manufacturing Changes Can Create Risk For MSCs
- 11.03.26 -- Advancing CGT Delivery, Regulatory Strategy With Axiom's Dr. Remo Moomiaie-Qajar
- 11.02.26 -- Why Human-Relevant Models Are Reshaping Early Drug Discovery
- 11.02.26 -- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

